Healing Touch and Relaxation Therapies in Cervical Cancer Patients

Sponsor
National Center for Complementary and Integrative Health (NCCIH) (NIH)
Overall Status
Completed
CT.gov ID
NCT00084123
Collaborator
(none)
60
1
3
55
1.1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effects of healing touch and relaxation therapy on cervical cancer patients undergoing chemotherapy and radiation treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Healing Touch Therapy
  • Behavioral: Relaxation Therapy
  • Behavioral: Standard Care
Phase 2

Detailed Description

The side effects of chemotherapy and radiation treatment are often severe and can have devastating effects on the mental and physical well-being of cancer patients. This study will determine whether healing touch and relaxation therapy are effective in minimizing the side effects of chemotherapy and radiation treatment in cervical cancer patients.

Participants in this study will receive weekly chemotherapy and daily radiation treatments for 6 weeks. Participants will be randomly assigned to receive either standard care (SC), SC plus relaxation therapy, or SC plus healing touch therapy. The relaxation therapy consists of progressive muscle relaxation and guided imagery. The healing touch therapy involves an energy-based modality in which health care practitioners stimulate the energy fields surrounding the patient. A physician-completed assessment and measures of immune function will be used to assess the well-being and overall quality of life of participants.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms
Study Start Date :
Sep 1, 2002
Actual Primary Completion Date :
Apr 1, 2007
Actual Study Completion Date :
Apr 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healing Touch

Healing Touch Therapy

Behavioral: Healing Touch Therapy

Active Comparator: Relaxation Therapy

Relaxation Therapy

Behavioral: Relaxation Therapy

Placebo Comparator: Standard Care

Standard Care

Behavioral: Standard Care
Standard Care

Outcome Measures

Primary Outcome Measures

  1. natural killer cell cytotoxicity [Baseline to week 6]

  2. T-cell counts [Baseline to week 6]

  3. side effects [Baseline to week 6]

Secondary Outcome Measures

  1. distress [Baseline to week 6]

  2. WBC and RBC [Baseline to week 6]

  3. days of treatment delay [Baseline to week 6]

  4. salivary cortisol [Baseline to post-treatment]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stage Ib1-IVa cervical cancer

  • Treatment with concurrent chemotherapy and radiation at the University of Iowa Hospitals and Clinics

Exclusion Criteria:
  • Immunosuppressive disorders

  • Use of immunosuppressive medications

  • Transplant recipient

  • Metastatic or recurrent cervical cancer

  • History of any other type of cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Iowa Hospital and Clinics Iowa City Iowa United States 52242

Sponsors and Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

Investigators

  • Principal Investigator: Susan K Lutgendorf, MD, University of Iowa

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00084123
Other Study ID Numbers:
  • P20AT000756-01
  • NCT00065091
First Posted:
Jun 8, 2004
Last Update Posted:
Jul 10, 2009
Last Verified:
Jul 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 10, 2009